Riboflavin Production via CcpC Transcription Factor Knockout
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biotechnological processes for riboflavin production, particularly using Bacillus subtilis, face challenges in yield and production rate, necessitating improved metabolic control and host cell modifications to enhance enzyme activities involved in riboflavin synthesis.
Innovation Solution
Reducing the activity or concentration of the transcription factor CcpC, which regulates the tricarboxylic acid cycle, leads to increased riboflavin production without affecting biomass production or cell growth rate, achieved through knockout mutations or underexpression of the ccpC gene in microbial hosts like Bacillus subtilis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If the activity of transcription factor CcpC is reduced to increase riboflavin production, then riboflavin yield is improved, but enzyme activities in TCA cycle may be affected
Solution Approach 1:
The invention extracts and removes the regulatory constraint imposed by transcription factor CcpC on riboflavin production. By reducing or eliminating CcpC activity through knockout mutations or antisense RNA, the patent isolates the riboflavin synthesis pathway from TCA cycle regulatory control, allowing independent optimization of riboflavin yield without being constrained by energy metabolism requirements
Solution Approach 2:
The invention segments the metabolic control system by separating riboflavin synthesis regulation from TCA cycle regulation. Through targeted modification of ccpC gene expression, the patent creates independent control modules where riboflavin production can be optimized separately from energy metabolism, enabling simultaneous improvement of both functions through staged optimization
2Productivity
If gene expression of ccpC is suppressed to increase riboflavin production rate, then productivity is improved, but cell growth rate may be affected
Solution Approach 1:
The invention applies partial action by using moderate reductions in CcpC activity (through knockout mutations or antisense RNA) rather than complete elimination. This partial modification is sufficient to解除 TCA cycle constraints on riboflavin production while maintaining adequate energy metabolism to support normal cell growth rates, achieving the optimal balance between productivity improvement and growth maintenance
Data Source
AI summary
The invention relates to processes and means for the biotechnologically fermentative production of riboflavin (hereinafter also referred to as vitamin B2) and means for the implementation of this process, in particular a modified microbial host cell with increased riboflavin yield. The invention thus provides new processes and means for the regulation of the expression of enzyme activities involved in the riboflavin production of the host cell.